FAZ Fees and Costs — Direxion Daily Financial Bear 3X Shares

Data updated: 2026-09-28

The net expense ratio is 1.04%. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $261K in broker commissions, 0.2465% of average net assets, and portfolio turnover was 0%.

FAZ Fees and Expenses

Annual operating expenses and sales charges of FAZ. Prospectus, as of February 28, 2025.

Annual operating expenses
Management fee0.75%
12b-1 fee0.00%
Other expenses0.16%
Gross expense ratio1.04%
Fee waiver—
Net expense ratio1.04%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentYes

FAZ Costs Over Time

On $10,000 invested in FAZ, assuming 5% a year before costs, total costs come to $800 over 5 years, cutting the return by 1.35% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.04%)$109$340$587
Trading costs (broker commissions)$26$81$139
Lost growth on money paid in costs$0$21$74
Total costs$135$441$800
Value after costs$10,365$11,135$11,963
Impact on return, per year1.35%1.35%1.35%

FAZ Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): 0.2465%
  • Total broker commissions: $261K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 0%
  • Securities lending: none during the year

FAZ Agency Brokers

Commissions paid.

BrokerAmountShare
Bank of America N.A.$133K51.01%
Goldman Sachs & Co. LLC$58K22.04%
JPMorgan Chase Bank, National Association$36K13.75%
UBS AG$34K13.20%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.